Tokyo, Japan

Atsushi Iesato

This inventor holds 1 USPTO granted patent. Top assignee: Asahi Kasei Pharma Corporation. Active years: 2011.


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2011

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Atsushi Iesato: Innovator in Sulfonamide Compounds

Introduction

Atsushi Iesato is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of sulfonamide compounds. His work has implications for various medical applications, showcasing his innovative spirit and dedication to advancing science.

Latest Patents

Atsushi Iesato holds a patent for a sulfonamide compound that is represented by a complex formula. This compound is designed to potently inhibit Rho kinase, which is crucial in various biological processes. The patent details a compound that includes various functional groups and structural components, highlighting the intricate nature of his invention. He has 1 patent to his name, reflecting his focused contributions to the field.

Career Highlights

Iesato is currently associated with Asahi Kasei Pharma Corporation, where he continues to innovate and develop new pharmaceutical solutions. His work at the company emphasizes the importance of research and development in the pharmaceutical industry. His career is marked by a commitment to improving health outcomes through scientific advancements.

Collaborations

Throughout his career, Atsushi Iesato has collaborated with esteemed colleagues such as Akifumi Oomura and Koh Kawasaki. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries.

Conclusion

Atsushi Iesato is a prominent figure in the field of pharmaceutical innovation, particularly known for his work on sulfonamide compounds. His contributions continue to influence the industry and pave the way for future advancements in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…